As described above, the inactivation of ELF3 increased the rate of cell death and decreased FOXM1 levels in NSCLC with K-Ras and EGFR T790M/L858R mutations in vitro and in vivo. This evidence concerns the gene EGFR and non-small cell lung carcinoma.